L. Royer

发表

The hydrophobic tunnel present in LOX-1 is essential for oxidized LDL recognition and binding Published, JLR Papers in Press, October 9, 2008.

O. Francone, M. Tu, L. Royer, 2009, Journal of Lipid Research.

Synthesis and evaluation of novel alpha-heteroaryl-phenylpropanoic acid derivatives as PPARalpha/gamma dual agonists.

J. Ohren, L. Royer, Kimberly A Stevens, 2009, Bioorganic & medicinal chemistry.

Relationship between Expression Levels and Atherogenesis in Scavenger Receptor Class B, Type I Transgenics*

E. Rubin, E. Gong, O. Francone, 2000, The Journal of Biological Chemistry.

Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I.

A. Tall, X. Jiang, H. Oliveira, 1999, Journal of lipid research.

Molecular Characterization of Novel and Selective Peroxisome Proliferator-Activated Receptor (cid:1) Agonists with Robust Hypolipidemic Activity in Vivo □ S

P. Zagouras, O. Francone, L. Royer, 2009 .

Increased Cholesterol Deposition, Expression of Scavenger Receptors, and Response to Chemotactic Factors in Abca1-Deficient Macrophages

O. Francone, L. Royer, D. Brees, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes.

O. Francone, L. Royer, M. Haghpassand, 1996, Journal of lipid research.

A Selective Peroxisome Proliferator-Activated Receptor α Agonist, CP-900691, Improves Plasma Lipids, Lipoproteins, and Glycemic Control in Diabetic Monkeys

O. Francone, L. Royer, B. Auerbach, 2010, Journal of Pharmacology and Experimental Therapeutics.

A critical role for peroxisomal proliferator-activated receptor-alpha nuclear receptors in the development of cardiomyocyte degeneration and necrosis.

O. Francone, L. Royer, C. Kane, 2006, The American journal of pathology.

Aldosterone production in human adrenocortical cells is stimulated by high-density lipoprotein 2 (HDL2) through increased expression of aldosterone synthase (CYP11B2).

W. Rainey, O. Francone, L. Royer, 2011, Endocrinology.

Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridemic subjects.

J. Paul, N. Fournier, M. Cambillau, 2003, Atherosclerosis.

Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid.

O. Francone, L. Royer, G. Rothblat, 1997, Journal of lipid research.

Pharmacokinetics, disposition and lipid-modulating activity of 5-{2-[4-(3,4-difluorophenoxy)-phenyl]-ethylsulfamoyl}-2-methyl-benzoic acid, a potent and subtype-selective peroxisome proliferator-activated receptor α agonist in preclinical species and human

A. Kalgutkar, T. Maurer, S. Winter, 2009, Xenobiotica; the fate of foreign compounds in biological systems.

Lower Plasma Levels and Accelerated Clearance of High Density Lipoprotein (HDL) and Non-HDL Cholesterol in Scavenger Receptor Class B Type I Transgenic Mice*

E. Rubin, E. Gong, O. Francone, 1999, The Journal of Biological Chemistry.

High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1.

C. Gabel, J. Mcneish, G. Chimini, 2000, Proceedings of the National Academy of Sciences of the United States of America.

The Correlation of ATP-binding Cassette 1 mRNA Levels with Cholesterol Efflux from Various Cell Lines*

J. Mcneish, O. Francone, L. Royer, 2000, The Journal of Biological Chemistry.

Molecular Characterization of Novel and Selective Peroxisome Proliferator-Activated Receptor α Agonists with Robust Hypolipidemic Activity in Vivo

P. Zagouras, O. Francone, L. Royer, 2009, Molecular Pharmacology.

Effects of modifications of the linker in a series of phenylpropanoic acid derivatives: Synthesis, evaluation as PPARalpha/gamma dual agonists, and X-ray crystallographic studies.

Hairong Zhou, J. Ohren, L. Royer, 2008, Bioorganic & medicinal chemistry.

Disruption of the murine procollagen C-proteinase enhancer 2 gene causes accumulation of pro-apoA-I and increased HDL levels

A. Burlingame, J. Kane, O. Francone, 2011, Journal of Lipid Research.

Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport.

J. Mcneish, O. Francone, L. Royer, 1997, Journal of lipid research.

Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages

O. Francone, L. Royer, T. Coskran, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Abnormal phospholipid composition impairs HDL biogenesis and maturation in mice lacking Abca1.

P. Subbaiah, A. van Tol, O. Francone, 2003, Biochemistry.

Phospholipid transfer protein deficiency ameliorates diet-induced hypercholesterolemia and inflammation in mice Published, JLR Papers in Press, January 14, 2008.

L. Royer, T. Sand, Yi Luo, 2008, Journal of Lipid Research.

Molecular Characterization of Novel and Selective Peroxisome Proliferator-Activated Receptor α Agonists with Robust Hypolipidemic Activity in Vivo

P. Zagouras, O. Francone, L. Royer, 2009, Molecular Pharmacology.

The hydrophobic tunnel present in LOX-1 is essential for oxidized LDL recognition and binding Published, JLR Papers in Press, October 9, 2008.

O. Francone, M. Tu, L. Royer, 2009, Journal of Lipid Research.